Jae B. Park
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jae B. Park has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Renee Peters
5 shared publications- Thomas T. Y. Wang
Diet, Genomics, and Immunology Laboratory, Beltsville Human Nutrition Research Center, Agricultural Research Service, United States Department of Agriculture, Beltsville, MD
5 shared publications - Doina Clapa
Faculty of Horticulture and Business in Rural Development, University of Agricultural Sciences and Veterinary Medicine of Cluj-Napoca, 3-5 Manastur St., 400372 Cluj-Napoca, Romania
2 shared publications - Liliana Mureșan
Diet, Genomics and Immunology Laboratory, Beltsville Human Nutrition Research Center, Agricultural Research Service, U.S. Department of Agriculture, Beltsville, MD 20705, USA
2 shared publications - Quynhchi Pham
Diet, Genomics, and Immunology Laboratory, Beltsville Human Nutrition Research Center, USDA-ARS, Beltsville, MD 20705, USA
2 shared publications - Teodor Rusu
Department of Technical and Soil Sciences, Faculty of Agriculture, University of Agricultural Sciences and Veterinary Medicine Cluj-Napoca, Mănăstur Street 3–5, 400372 Cluj-Napoca, Romania
2 shared publications
Latest Publications
- Open Access
- 26 September 2026
- Published by MDPI AG in Inflammation Journal
- Vol. 1 (1) , 4
Hypoxia and Serum Factor Modulate B7-H3 Expression in Prostate Cancer Cells
Background: Data on the expression and regulation of immune checkpoint inhibitors in prostate tissue and cells remain limited. This study aims to characterize the expression and regulatory mechanisms of B7-H3 (CD276) in prostate tissues and cell models. Methods: In silico analyses were performed to evaluate the expression of B7-H3 and other checkpoint inhibitors in prostate tissues and cell lines. In vitro experiments assessed the impact of tumor microenvironmental factors on B7-H3 expression. Results: B7-H3 was identified as the most abundant checkpoint inhibitor in prostate tissues and cell lines. Its expression was highest in androgen-responsive LNCaP cells compared to other commonly used prostate cancer models. Hypoxic conditions and charcoal dextran-treated serum (CDS) significantly reduced B7-H3 mRNA and protein levels in LNCaP cells but not in androgen-independent DU145 or PC3 cells. Conversely, dihydrotestosterone (DHT) did not influence B7-H3 expression. Conclusion: B7-H3, rather than other checkpoint inhibitors, may play a critical role in prostate cancer tumorigenesis. Hypoxia, rather than androgen signaling, appears to regulate B7-H3 expression, and this regulatory response may be lost in more aggressive androgen-independent prostate cancer cells.
- 26 September 2026
- Published by MDPI AG in Inflammation Journal
- Vol. 1 (1) , 4
Open AccessHypoxia and Serum Factor Modulate B7-H3 Expression in Prostate Cancer Cells
Background: Data on the expression and regulation of immune checkpoint inhibitors in prostate tissue and cells remain limited. This study aims to characterize the expression and regulatory mechanisms of B7-H3 (CD276) in prostate tissues and cell models. Methods: In silico analyses were performed to evaluate the expression of B7-H3 and other checkpoint inhibitors in prostate tissues and cell lines. In vitro experiments assessed the impact of tumor microenvironmental factors on B7-H3 expression. Results: B7-H3 was identified as the most abundant checkpoint inhibitor in prostate tissues and cell lines. Its expression was highest in androgen-responsive LNCaP cells compared to other commonly used prostate cancer models. Hypoxic conditions and charcoal dextran-treated serum (CDS) significantly reduced B7-H3 mRNA and protein levels in LNCaP cells but not in androgen-independent DU145 or PC3 cells. Conversely, dihydrotestosterone (DHT) did not influence B7-H3 expression. Conclusion: B7-H3, rather than other checkpoint inhibitors, may play a critical role in prostate cancer tumorigenesis. Hypoxia, rather than androgen signaling, appears to regulate B7-H3 expression, and this regulatory response may be lost in more aggressive androgen-independent prostate cancer cells.
- Open Access
- 29 July 2026
- Published by Elsevier in SSRN Electronic Journal
Investigation of compositions, differential metabolite changes and pathway enrichments of alkaloids, amino acids, javamide-II, phenolics and related compounds in light, medium and dark roast Arabica beans using LC/MS and HPLC
In this paper, we investigated roasting effect on the compositions, differential changes and enrichment of AAJPRC in Arabica beans. Arabica beans (n=9) were placed into three groups (n=3), roasted at light, medium and dark levels, and investigated using LC/MS and HPLC. PCA, HCA and OPLS-DA exhibited distinct separations between light, medium and dark roast beans. As expected, 95 AAJPRC were down (FC ≤ -1 and p < 0.05) and 72 AAJPRC were up (FC ≥1 and p < 0.05) by roasting from light to medium level, and 77 AAJPRC were down (FC ≤ -1 and p < 0.05) and 94 AAJPRC were up (FC ≥1 and p < 0.05) by roasting from medium to dark level. During roasting, well-known antioxidant compounds (e.g., CQAs, javamide-II) decreased, but some neuroactive compounds (e.g., dopa, methyldopa, norharman) increased. Lastly, KEGG analysis showed that some coffee compounds were found to be enriched by roasting, related to several metabolic/biological pathways (e.g., indole alkaloid and central carbon metabolism in cancer). Altogether, this data shows that roasting can have significant impacts on AAJPRC including antioxidant/anti-inflammatory and neuroactive compounds in Arabica beans, suggesting that coffee beans roasted at different levels may have different biological profiles.
- 29 July 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessInvestigation of compositions, differential metabolite changes and pathway enrichments of alkaloids, amino acids, javamide-II, phenolics and related compounds in light, medium and dark roast Arabica beans using LC/MS and HPLC
In this paper, we investigated roasting effect on the compositions, differential changes and enrichment of AAJPRC in Arabica beans. Arabica beans (n=9) were placed into three groups (n=3), roasted at light, medium and dark levels, and investigated using LC/MS and HPLC. PCA, HCA and OPLS-DA exhibited distinct separations between light, medium and dark roast beans. As expected, 95 AAJPRC were down (FC ≤ -1 and p < 0.05) and 72 AAJPRC were up (FC ≥1 and p < 0.05) by roasting from light to medium level, and 77 AAJPRC were down (FC ≤ -1 and p < 0.05) and 94 AAJPRC were up (FC ≥1 and p < 0.05) by roasting from medium to dark level. During roasting, well-known antioxidant compounds (e.g., CQAs, javamide-II) decreased, but some neuroactive compounds (e.g., dopa, methyldopa, norharman) increased. Lastly, KEGG analysis showed that some coffee compounds were found to be enriched by roasting, related to several metabolic/biological pathways (e.g., indole alkaloid and central carbon metabolism in cancer). Altogether, this data shows that roasting can have significant impacts on AAJPRC including antioxidant/anti-inflammatory and neuroactive compounds in Arabica beans, suggesting that coffee beans roasted at different levels may have different biological profiles.
- Open Access
- 10 October 2025
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 12, 1661468
In vivo effects of javamide-I/-II on metabolic, hepatic, cardiovascular and inflammatory risk factors
Background: Javamide-I/-II (J1/J2) are bioactive compounds found in coffee. Recent studies suggest that J1/J2 may possess anti-inflammatory activity. However, there is no information about the effects of J1/J2 on inflammatory cytokines and other health-related factors in vivo.Methods: To investigate the effects of J1/J2 on inflammatory and other health-related factors (metabolic/growth/hepatic/cardiovascular/ risk factors) in vivo, rats were placed into two groups: CG group (a control diet/drinking water, n = 10) and JG group (a normal diet/drinking water containing J1/J2, n = 10). The study was performed for 16 weeks. During the study, bodyweight and water consumption were monitored weekly, and O-red/HE stains, ALT, AST, IGF1, IGF-1, growth hormone, sE-selectin, sICAM, TNF-alpha, and MCP-1 assays were performed using histochemistry and ELISA methods. The amounts of J1/J2 were measured by HPLC.Results: The average daily intakes of J1 and J2 were found to be about 0.13 and 0.38 mg, respectively, and no significant difference in bodyweight was found between the CG and JG groups. Also, O-red/HE stains showed no significant difference between both groups, suggesting that J1/J2 may have no adverse effect on the liver. Also, there was no difference in ALT level between both groups. However, the level of AST was significantly lower in the JG group compared to the CG group (p < 0.05). Additionally, J1/J2 had no significant effects on growth hormone (GH) and IGF-1 in the JG group, compared to the CG group. Also, there was no significant difference in sE-selectin and sICAM levels between both groups. However, TNF-alpha and MCP-1 levels were significantly lower in the JG group, compared to the CG group (p < 0.05), suggesting that J1/J2 may have positive effects on these inflammatory cytokines in vivo.Conclusion: J1/J2 may have beneficial effects on hepatic and inflammatory factors (AST, TNF-alpha and MCP-1) without adverse effects on bodyweight, liver, ALT, GH, IGF-1, sE-selectin, and sICAM in rats.
- 10 October 2025
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 12, 1661468
Open AccessIn vivo effects of javamide-I/-II on metabolic, hepatic, cardiovascular and inflammatory risk factors
Background: Javamide-I/-II (J1/J2) are bioactive compounds found in coffee. Recent studies suggest that J1/J2 may possess anti-inflammatory activity. However, there is no information about the effects of J1/J2 on inflammatory cytokines and other health-related factors in vivo.Methods: To investigate the effects of J1/J2 on inflammatory and other health-related factors (metabolic/growth/hepatic/cardiovascular/ risk factors) in vivo, rats were placed into two groups: CG group (a control diet/drinking water, n = 10) and JG group (a normal diet/drinking water containing J1/J2, n = 10). The study was performed for 16 weeks. During the study, bodyweight and water consumption were monitored weekly, and O-red/HE stains, ALT, AST, IGF1, IGF-1, growth hormone, sE-selectin, sICAM, TNF-alpha, and MCP-1 assays were performed using histochemistry and ELISA methods. The amounts of J1/J2 were measured by HPLC.Results: The average daily intakes of J1 and J2 were found to be about 0.13 and 0.38 mg, respectively, and no significant difference in bodyweight was found between the CG and JG groups. Also, O-red/HE stains showed no significant difference between both groups, suggesting that J1/J2 may have no adverse effect on the liver. Also, there was no difference in ALT level between both groups. However, the level of AST was significantly lower in the JG group compared to the CG group (p < 0.05). Additionally, J1/J2 had no significant effects on growth hormone (GH) and IGF-1 in the JG group, compared to the CG group. Also, there was no significant difference in sE-selectin and sICAM levels between both groups. However, TNF-alpha and MCP-1 levels were significantly lower in the JG group, compared to the CG group (p < 0.05), suggesting that J1/J2 may have positive effects on these inflammatory cytokines in vivo.Conclusion: J1/J2 may have beneficial effects on hepatic and inflammatory factors (AST, TNF-alpha and MCP-1) without adverse effects on bodyweight, liver, ALT, GH, IGF-1, sE-selectin, and sICAM in rats.
- Open Access
- 6 August 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-13
Compositional analysis of coffee containing javamide I/II and investigation of health effects in rats fed a high fat diet
Coffee containing javamide I/II (CCJ12) is commonly found in the market. However, no information is available about chemical composition of CCJ12 and in vivo effects on obesity. Therefore, in this paper, the composition of CCJ12 was analyzed by HPLC and LC/MS, and effects on bodyweight, metabolic (HDL, LDL, TG, leptin, adiponectin), cardiovascular risk (sE-selectin, C-reactive protein,), and inflammatory (MCP-1, TNF-alpha) factors were investigated in a rodent model. In CCJ12, > 700 compounds were identified by LC/MS and the amounts of javamide I/II, caffeine and chlorogenic acids were quantified by HPLC. For the animal study, rats were placed into three groups (each n = 10); (CG group (a control diet with water), FG group (a high fat diet with water), and FCG group (a high fat diet with CCJ12)) and the study was conducted for 20 weeks. The data showed no significant differences in water/food intakes between all three groups. However, the FG and FCG groups showed weight gain, in comparison to the CG group (P < 0.05). Also, the FG and FCG groups showed higher levels of LDL, TG, and leptin than the CG group (P < 0.05). However, no significant differences were found in bodyweight, HDL, LDL, TG, leptin, and adiponectin levels between the FG and FCG groups. Also, no significant differences were noted in sE-selectin, C-reactive protein, and MCP-1 levels between the FG and FCG groups. However, TNF-alpha level was found to be down in the FCG group, in comparison to the FG group (P < 0.05). Our study suggests that CCJ12 may have no adverse effects on bodyweight, HDL, LDL, TG, adiponectin, leptin, sE-selectin, C-reactive protein, and MCP-1, but may have a beneficial effect on TNF-alpha in rats fed a high fat diet.
- 6 August 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-13
Open AccessCompositional analysis of coffee containing javamide I/II and investigation of health effects in rats fed a high fat diet
Coffee containing javamide I/II (CCJ12) is commonly found in the market. However, no information is available about chemical composition of CCJ12 and in vivo effects on obesity. Therefore, in this paper, the composition of CCJ12 was analyzed by HPLC and LC/MS, and effects on bodyweight, metabolic (HDL, LDL, TG, leptin, adiponectin), cardiovascular risk (sE-selectin, C-reactive protein,), and inflammatory (MCP-1, TNF-alpha) factors were investigated in a rodent model. In CCJ12, > 700 compounds were identified by LC/MS and the amounts of javamide I/II, caffeine and chlorogenic acids were quantified by HPLC. For the animal study, rats were placed into three groups (each n = 10); (CG group (a control diet with water), FG group (a high fat diet with water), and FCG group (a high fat diet with CCJ12)) and the study was conducted for 20 weeks. The data showed no significant differences in water/food intakes between all three groups. However, the FG and FCG groups showed weight gain, in comparison to the CG group (P < 0.05). Also, the FG and FCG groups showed higher levels of LDL, TG, and leptin than the CG group (P < 0.05). However, no significant differences were found in bodyweight, HDL, LDL, TG, leptin, and adiponectin levels between the FG and FCG groups. Also, no significant differences were noted in sE-selectin, C-reactive protein, and MCP-1 levels between the FG and FCG groups. However, TNF-alpha level was found to be down in the FCG group, in comparison to the FG group (P < 0.05). Our study suggests that CCJ12 may have no adverse effects on bodyweight, HDL, LDL, TG, adiponectin, leptin, sE-selectin, C-reactive protein, and MCP-1, but may have a beneficial effect on TNF-alpha in rats fed a high fat diet.
- 2 November 2023
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 388 (1) , 181-189
Methyl 2-[3-(4-hydroxyphenyl)prop-2-enoylamino]-3-phenylpropanoate Is a Potent Cell-Permeable Anti-Cytokine Compound To Inhibit Inflammatory Cytokines in Monocyte/Macrophage-Like Cells
Cytokines are signaling molecules involved in inflammation process. Interleukin (IL)-6 is one of pivotal inflammatory cytokines associated with many human diseases. Therefore, there are on-going efforts to find a therapeutic to inhibit IL-6 and other cytokines. Methyl 2-[3-(4-hydroxyphenyl)prop-2-enoylamino]-3-phenylpropanoate (MHPAP) is a phenolic amide ester, transported better than its non-ester form (NEF) in monocyte/macrophage-like cells. However, there is no information about the effects of their cell permeability on cytokines. Therefore, the effects of MHPAP and NEF on cytokines were investigated in lipopolysaccharide (LPS)-stimulated THP-1 and human peripheral blood mononuclear cells (PBMCs). In the THP-1 cells, MHPAP significantly inhibited IL-6, IL-1beta, IL-8, and tumor necrosis factor (TNF)-alpha (P < 0.05), but NEF showed no effects. MHPAP also inhibited nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) p65 phosphorylation in the THP-1 cells (P < 0.05), without significant effects on c-FOS, ATF-2, and JUN phosphorylations. Because NF-κB p65 is phosphorylated by IκB kinase (IKK), in silico analysis was performed on IKK. MHPAP was found to bind to IKK better than an IKK inhibitor ((E)-2-fluoro-49-methoxystilbene). Furthermore, MHPAP inhibited the luminescence increased in the LPS-stimulated NF-κB-Luc2 THP-1 cells. As anticipated, MHPAP was also found to inhibit IL-6, IL-1beta, IL-8, and TNF-alpha significantly in LPS-stimulated PBMCs (P < 0.05). Especially, MHPAP inhibited IL-6 and IL-1beta with an IC50 of 0.85 and 0.87 µM, better than IL-8 (1.58 µM) and TNF-alpha (1.22 µM) in the cells. Altogether, the data suggest that cell permeability may have a significant impact on MHPAP’s ability to inhibit cytokines and MHPAP may be used as a potent cell-permeable compound to inhibit inflammatory cytokines in monocyte/macrophage-like cells. SIGNIFICANCE STATEMENT Potential effects of MHPAP and NEF on inflammatory cytokines (IL-6, IL-8, IL-1beta, and TNF-alpha) were investigated in LPS-stimulated THP-1 and PBMCs. Cell transport had a great impact on cytokine inhibition in the cells. MHPAP was also found to inhibit NF-κB pathway, which was supported by in silico and NF-κB reporter (Luc)-THP-1 data. Also, in LPS-stimulated PBMCs, MHPAP significantly inhibited IL-6, IL-1beta, IL-8, and TNF-alpha, suggesting that MHPAP may be a potent cell-permeable compound to inhibit inflammatory cytokines in monocyte/macrophage-like cells.
- 2 November 2023
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 388 (1) , 181-189
Methyl 2-[3-(4-hydroxyphenyl)prop-2-enoylamino]-3-phenylpropanoate Is a Potent Cell-Permeable Anti-Cytokine Compound To Inhibit Inflammatory Cytokines in Monocyte/Macrophage-Like Cells
Cytokines are signaling molecules involved in inflammation process. Interleukin (IL)-6 is one of pivotal inflammatory cytokines associated with many human diseases. Therefore, there are on-going efforts to find a therapeutic to inhibit IL-6 and other cytokines. Methyl 2-[3-(4-hydroxyphenyl)prop-2-enoylamino]-3-phenylpropanoate (MHPAP) is a phenolic amide ester, transported better than its non-ester form (NEF) in monocyte/macrophage-like cells. However, there is no information about the effects of their cell permeability on cytokines. Therefore, the effects of MHPAP and NEF on cytokines were investigated in lipopolysaccharide (LPS)-stimulated THP-1 and human peripheral blood mononuclear cells (PBMCs). In the THP-1 cells, MHPAP significantly inhibited IL-6, IL-1beta, IL-8, and tumor necrosis factor (TNF)-alpha (P < 0.05), but NEF showed no effects. MHPAP also inhibited nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) p65 phosphorylation in the THP-1 cells (P < 0.05), without significant effects on c-FOS, ATF-2, and JUN phosphorylations. Because NF-κB p65 is phosphorylated by IκB kinase (IKK), in silico analysis was performed on IKK. MHPAP was found to bind to IKK better than an IKK inhibitor ((E)-2-fluoro-49-methoxystilbene). Furthermore, MHPAP inhibited the luminescence increased in the LPS-stimulated NF-κB-Luc2 THP-1 cells. As anticipated, MHPAP was also found to inhibit IL-6, IL-1beta, IL-8, and TNF-alpha significantly in LPS-stimulated PBMCs (P < 0.05). Especially, MHPAP inhibited IL-6 and IL-1beta with an IC50 of 0.85 and 0.87 µM, better than IL-8 (1.58 µM) and TNF-alpha (1.22 µM) in the cells. Altogether, the data suggest that cell permeability may have a significant impact on MHPAP’s ability to inhibit cytokines and MHPAP may be used as a potent cell-permeable compound to inhibit inflammatory cytokines in monocyte/macrophage-like cells. SIGNIFICANCE STATEMENT Potential effects of MHPAP and NEF on inflammatory cytokines (IL-6, IL-8, IL-1beta, and TNF-alpha) were investigated in LPS-stimulated THP-1 and PBMCs. Cell transport had a great impact on cytokine inhibition in the cells. MHPAP was also found to inhibit NF-κB pathway, which was supported by in silico and NF-κB reporter (Luc)-THP-1 data. Also, in LPS-stimulated PBMCs, MHPAP significantly inhibited IL-6, IL-1beta, IL-8, and TNF-alpha, suggesting that MHPAP may be a potent cell-permeable compound to inhibit inflammatory cytokines in monocyte/macrophage-like cells.
- 30 January 2023
- Published by Elsevier in Food Chemistry
- Vol. 412, 135586
Impact of roasting on javamide-I/-II in Arabica and Robusta coffee beans
- 30 January 2023
- Published by Elsevier in Food Chemistry
- Vol. 412, 135586
Impact of roasting on javamide-I/-II in Arabica and Robusta coffee beans
- 1 May 2022
- Published by Bentham Science Publishers Ltd. in Current Nutraceuticals
- Vol. 3 (2) , 1
Efficient Transport and Biotransformation of Dipeptide-like Tyrosine/ Phenylalanine-Conjugated Phenolic Amide Esters in THP-1 Cells and PBMCs: A Potential Means for Transporting Compounds Inside Monocytes/Macrophages
Background: Recent studies suggest that dipeptide-like tyrosine/phenylalanine-conjugated phenolic amide compounds may contain several biological activities, including anti-inflammatory activity. However, there is currently no information about their transport and biotransformation in monocytes/macrophages involved in inflammation process. Objective: The objective of this study was to investigate cell transport and biotransformation of the phenolic amides and esters in monocyte/macrophage-like cells. Methods: Cell transport and biotransformation of the phenolic amides and esters (N-coumaroylphenylalanine, N-caffeoylphenylalanine, N-feruloylphenylalanine, N-coumaroyltyrosine, Ncaffeoyltyrosine, N-feruloyltyrosine, and their O-methyl esters) were investigated in THP-1 cells and PBMCs using HPLC, cellular, and kinetics methods. Results: In THP-1 cells, the phenolic amides were not transported significantly, but their O-methyl esters were transported significantly (P < 0.02). Also, the transport of the esters was found to be sodium-independent and pH-dependent. Among the tested esters, N-feruloylphenylalanine-Omethyl ester showed the highest uptake (Km of 25 μM), and the uptake was inhibited by PepT1/2 substrate and blocker (GlySar and enalapril) in THP-1 cells. Particularly, enalapril competitively inhibited the uptake with Ki of 560 μM. The data also showed that N-feruloylphenylalanine-Omethyl ester and N-feruloyltyrosine-O-methyl ester could be biotransformed into parent phenolic amides in THP-1 cells. Similarly, these ester compounds were also found to be transported and biotransformed in PBMCs. Conclusion: The data suggest that dipeptide-like tyrosine/phenylalanine-conjugated phenolic amide esters may be transported and biotransformed in THP-1 cells and PBMCs.
- 1 May 2022
- Published by Bentham Science Publishers Ltd. in Current Nutraceuticals
- Vol. 3 (2) , 1
Efficient Transport and Biotransformation of Dipeptide-like Tyrosine/ Phenylalanine-Conjugated Phenolic Amide Esters in THP-1 Cells and PBMCs: A Potential Means for Transporting Compounds Inside Monocytes/Macrophages
Background: Recent studies suggest that dipeptide-like tyrosine/phenylalanine-conjugated phenolic amide compounds may contain several biological activities, including anti-inflammatory activity. However, there is currently no information about their transport and biotransformation in monocytes/macrophages involved in inflammation process. Objective: The objective of this study was to investigate cell transport and biotransformation of the phenolic amides and esters in monocyte/macrophage-like cells. Methods: Cell transport and biotransformation of the phenolic amides and esters (N-coumaroylphenylalanine, N-caffeoylphenylalanine, N-feruloylphenylalanine, N-coumaroyltyrosine, Ncaffeoyltyrosine, N-feruloyltyrosine, and their O-methyl esters) were investigated in THP-1 cells and PBMCs using HPLC, cellular, and kinetics methods. Results: In THP-1 cells, the phenolic amides were not transported significantly, but their O-methyl esters were transported significantly (P < 0.02). Also, the transport of the esters was found to be sodium-independent and pH-dependent. Among the tested esters, N-feruloylphenylalanine-Omethyl ester showed the highest uptake (Km of 25 μM), and the uptake was inhibited by PepT1/2 substrate and blocker (GlySar and enalapril) in THP-1 cells. Particularly, enalapril competitively inhibited the uptake with Ki of 560 μM. The data also showed that N-feruloylphenylalanine-Omethyl ester and N-feruloyltyrosine-O-methyl ester could be biotransformed into parent phenolic amides in THP-1 cells. Similarly, these ester compounds were also found to be transported and biotransformed in PBMCs. Conclusion: The data suggest that dipeptide-like tyrosine/phenylalanine-conjugated phenolic amide esters may be transported and biotransformed in THP-1 cells and PBMCs.
- 1 January 2022
- Published by Elsevier in Life Sciences
- Vol. 291, 120280
Finding a cell-permeable compound to inhibit inflammatory cytokines: Uptake, biotransformation, and anti-cytokine activity of javamide-I/-II esters
- 1 January 2022
- Published by Elsevier in Life Sciences
- Vol. 291, 120280
Finding a cell-permeable compound to inhibit inflammatory cytokines: Uptake, biotransformation, and anti-cytokine activity of javamide-I/-II esters